Skip to main content

In this Issue

  • Personalized wellness: Q&A with Ūnomi's Pam Helmly

    Drug Store News caught up with Ūnomi founder and CSO Pam Helmly for a rundown on the brand and how it will change personalized wellness.

  • Bayer leads sales, ads in nasal sprays

    The nasal spray segment is up 2% from the previous year in the drug channel. Nasal spray segment leaders Afrin (Bayer), NeilMed and private label have all increased sales in the last year. Private label nasal sprays and Afrin both rose 6%, while NeilMed sinus rinse brand saw the largest increase in the segment at 14.3% — all NeilMed products rose 7%.

  • Color-correcting options provide lift

    When Sephora introduced its compact contour app two years ago, it ignited the contouring trend. Now, Sephora has put its efforts behind teaching women how to “cancel out color concerns.”

  • Maintaining eye health: Q&A with Prestige Brands’ Joseph Juliano

    Joseph Juliano, VP marketing for analgesics, eye care and marketing services at Prestige Brands

    Prestige Brands has introduced the first preservative-free eye drop in a multi-dose bottle in the United States with Clear Eyes Pure Relief. Drug Store News sat down with Joseph Juliano, VP marketing for analgesics, eye care and marketing services at Prestige Brands, to discuss the brand launch, along with trends impacting the overall eye care category.

  • Specialty drives double-digit growth

    For the second year in a row, spending on medicines in 2015 grew by double-digits, increasing 12.2% on an invoice basis to $424.8 billion, according to the IMS Institute for Healthcare Informatics’ medicine report on spending for 2015.

  • Wipe the day away with Simple’s reformulated cleansing wipes

    ENGLEWOOD CLIFFS, N.J. — Wipe technology has made big waves in facial cleansers. Simple Wipes were a big part of that growth. Now Unilever’s Simple has upped its game.

  • Baby boomers boost category growth

    Adult incontinence is growing by 7%, and with incontinence and bladder leakage a common ailment among baby boomers, that growth is expected to maintain its upward trajectory.

  • Big-money meds lose patent protection in 2016

    Total spending on products whose patents expired between 2012 and 2015 declined by $14.2 billion last year, according to IMS Health’s Institute for Health Care informatics. And 2016 could bring about further cost reductions.

X
This ad will auto-close in 10 seconds